Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Farrell

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Multiple Sclerosis and Related Disorders|August 6, 2024
A randomized, double-blind, placebo-controlled trial to evaluate the effect of nabiximols oromucosal spray on clinical measures of spasticity in patients with multiple sclerosisFrancois A Bethoux, Rachel Farrell, Daniel Checketts, et al.
Practical Neurology|March 7, 2023
Managing painful shoulder after neurological injuryCeline Lakra, Rachel Higgins, Benjamin Beare, et al.
Clinical Rehabilitation|September 23, 2011
Patient inclusion in goal setting during early inpatient rehabilitation after acquired brain injuryCatherine Dalton, Rachel Farrell, Annette De Souza, et al.
Clinical Immunology (Orlando, Fla.)|August 13, 2024
Patients with multiple sclerosis who develop immunogenicity to interferon-beta have distinct transcriptomic and proteomic signatures prior to treatment which are associated with disease severityLeda Coelewij, Marsilio Adriani, Pierre Dönnes, et al.
Iscience|March 4, 2024
Blood metabolomic and transcriptomic signatures stratify patient subgroups in multiple sclerosis according to disease severityAlexandra E Oppong, Leda Coelewij, Georgia Robertson, et al.
JACC. Case Reports|March 29, 2024
Mitral Annular Disjunction: An Under-Recognized Entity in PediatricsFahad A Alfares, Jae Ho Sohn, Yoo Jin Lee, et al.
The Journal of Pediatrics|March 16, 2015
Treatment of methylmalonic acidemia by liver or combined liver-kidney transplantationAnna-Kaisa Niemi, Irene K Kim, Casey E Krueger, et al.
Frontiers in Immunology|August 9, 2020
Using Serum Metabolomics to Predict Development of Anti-drug Antibodies in Multiple Sclerosis Patients Treated With IFNβKirsty E Waddington, Artemis Papadaki, Leda Coelewij, et al.
Clinical and Experimental Immunology|April 16, 2024
Dysregulated lipid metabolism networks modulate T-cell function in people with relapsing-remitting multiple sclerosisLucia Martin-Gutierrez, Kirsty E Waddington, Annalisa Maggio, et al.
The Tohoku Journal of Experimental Medicine|September 15, 2012
Neutralizing antibodies are associated with a reduction of interferon-β efficacy during the treatment of Japanese multiple sclerosis patientsDouglas Kazutoshi Sato, Ichiro Nakashima, Toshiyuki Fukazawa, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Multiple Sclerosis and Related Disorders|August 6, 2024
A randomized, double-blind, placebo-controlled trial to evaluate the effect of nabiximols oromucosal spray on clinical measures of spasticity in patients with multiple sclerosisFrancois A Bethoux, Rachel Farrell, Daniel Checketts, et al.
Practical Neurology|March 7, 2023
Managing painful shoulder after neurological injuryCeline Lakra, Rachel Higgins, Benjamin Beare, et al.
Clinical Rehabilitation|September 23, 2011
Patient inclusion in goal setting during early inpatient rehabilitation after acquired brain injuryCatherine Dalton, Rachel Farrell, Annette De Souza, et al.
Clinical Immunology (Orlando, Fla.)|August 13, 2024
Patients with multiple sclerosis who develop immunogenicity to interferon-beta have distinct transcriptomic and proteomic signatures prior to treatment which are associated with disease severityLeda Coelewij, Marsilio Adriani, Pierre Dönnes, et al.
Iscience|March 4, 2024
Blood metabolomic and transcriptomic signatures stratify patient subgroups in multiple sclerosis according to disease severityAlexandra E Oppong, Leda Coelewij, Georgia Robertson, et al.
JACC. Case Reports|March 29, 2024
Mitral Annular Disjunction: An Under-Recognized Entity in PediatricsFahad A Alfares, Jae Ho Sohn, Yoo Jin Lee, et al.
The Journal of Pediatrics|March 16, 2015
Treatment of methylmalonic acidemia by liver or combined liver-kidney transplantationAnna-Kaisa Niemi, Irene K Kim, Casey E Krueger, et al.
Frontiers in Immunology|August 9, 2020
Using Serum Metabolomics to Predict Development of Anti-drug Antibodies in Multiple Sclerosis Patients Treated With IFNβKirsty E Waddington, Artemis Papadaki, Leda Coelewij, et al.
Clinical and Experimental Immunology|April 16, 2024
Dysregulated lipid metabolism networks modulate T-cell function in people with relapsing-remitting multiple sclerosisLucia Martin-Gutierrez, Kirsty E Waddington, Annalisa Maggio, et al.
The Tohoku Journal of Experimental Medicine|September 15, 2012
Neutralizing antibodies are associated with a reduction of interferon-β efficacy during the treatment of Japanese multiple sclerosis patientsDouglas Kazutoshi Sato, Ichiro Nakashima, Toshiyuki Fukazawa, et al.
Pageof 5